083790 fundamentals

CG Invites Co., Ltd. engages in the discovery and development of novel therapeutics. The company operates through the following business divisions: Research and Development, New Drug Development division, New Drug Sales, Products Sales, and Real Estate Leasing. The Research and Development division provides analysis of clinical trials services. The New Drug Development division engages in the development of anti-cancer remedies, antibiotics, diabetes treatments, remedies for hypoxia diseases, obesity treatment medicines and others. The company was founded by Cho Joong Myung and Ro Seong Gu on July 7, 2000 and is headquartered in Seongnam-si, South Korea.